FDAnews Announces — Leveraging Social Media in Pharma:The Hidden Message from the Masses Webinar, Feb. 16, 2016

Share Article

The billions of conversations taking place on social media provide drug companies with a big opportunity to leverage their data and metadata. To turn this data into useful information for decision-making, strategies and processes need to be developed.

Leveraging Social Media in Pharma:
The Hidden Message from the Masses
Feb. 16, 2016 — 1:30 p.m. – 3:00 p.m. EST
http://www.fdanews.com/leveragingsocialmedia

Social media poses a unique set of challenges to the drug industry — from identification of adverse events to FDA restrictions on marketing.

The billions of conversations taking place on social media provide drug companies with a big opportunity to leverage their data and metadata. To turn this data into useful information for decision-making, strategies and processes need to be developed.

Join social media experts, John MacDonald and Phil Baumann, of C3i Healthcare on Feb. 16 as they discuss how to best use social media. They will focus on the following:

  •     The value and relevance of social media data
  •     Why and how monitoring social media conversations presents an important opportunity
  •     How to overcome concerns about adverse events and product quality complaints by demonstrating a process workflow for identification and proper triaging
  •     The components and detail of structuring data into meaningful elements
  •     The different approaches between monitoring HCP and consumer conversations
  •     Technological considerations
  •     Best practices for monitoring and interacting on social media platforms

The conversations are happening and it’s time to capture them and use them to the company’s advantage. Register for Leveraging Social Media in Pharma today.

Meet the Presenters:
John MacDaniel, Director VOB/Digital, C3i Healthcare, a Division of Telerx
John MacDaniel has 25+ years of experience in the contract center industry. His background includes contact center operations, training, quality and customer experience. Since 2008, John has focused on social media, with a bent on defining and expanding the contact center's role in supporting brand social media initiatives.

Phil Baumann, Social Media Strategist, C3i Healthcare, a Division of Telerx
Phil Baumann is Social Media Strategist at C3i Healthcare Connections. A registered nurse with a diverse background in regulated industries, Phil brings an unique set of experiences to implementing digital solutions for clients facing regulatory challenges. He was a founding member of the external advisory board for the Mayo Clinic Center for Social Media. He also started the first clinical Twitter chats, MDchat and RNchat, which have since inspired hundreds of other Healthcare-related discussions on social media.

Who Will Benefit:

  •     Auditors
  •     Compliance officers
  •     Consultants/service providers
  •     Data management and statistics personnel
  •     Executive management
  •     General/corporate counsel
  •     Investigators
  •     Managers
  •     Manufacturing directors and supervisors
  •     Personnel new to the industry
  •     Pharmaceutical and cGMP auditors
  •     Regulatory/legislative affairs professionals
  •     Risk management specialists
  •     Strategic planning and business development staff

Webinar Details:
Leveraging Social Media in Pharma:
The Hidden Message from the Masses
Feb. 16, 2016 — 1:30 p.m. – 3:00 p.m. EST
http://www.fdanews.com/leveragingsocialmedia

Tuition:
$287 per site

Easy Ways to Register:
Online:     http://www.fdanews.com/leveragingsocialmedia
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website